17-May-2019 | Zion Market Research
Zion Market Research has published a new report titled “Nanoemulsion Market by Drug Class (Anesthetics, Steroids, NSAIDs, Immunosuppressant, Antimicrobials, Antiretroviral, Vasodilators, and Others), by Route of Administration (Topical, Parenteral, Oral, and Nasal), and by Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global nanoemulsion market was approximately USD 8,095 million in 2018 and is expected to generate around USD 15,290 million by 2025, at a CAGR of around 9.5 % between 2019 and 2025.
Nanoemulsion is the novel drug delivery system or targeted drug delivery system that consists of water and emulsified oil with an average droplet diameter ranging from 50 to 1000 nm. Water in oil and oil in water are the two types of emulsion phases, which depends on the core particle that is either water or oil. The nanoemulsion-based drugs provide increased bioavailability of the drug molecule by providing target specific drug delivery. The nanoemulsion technique is used for drugs or active pharmaceutical ingredients whose solubility is low to poor. The nanoemulsions have good capacity to dissolve low soluble drugs and protect the drugs from enzymatic degradation or hydrolysis. The major advantages of nanoemulsions as drug delivery carriers include improved drug loading, enhanced bioavailability, and drug solubility, controlled drug release, and reduced patient variability and protection from enzymatic degradation. This is the major factor driving the global nanoemulsion market. The global nanoemulsion market is also fuelled by the emergence of advanced technologies for drug and formulation developments, increasing research and development activities, and the rising prevalence of chronic diseases globally.
Browse the full “Nanoemulsion Market by Drug Class (Anesthetics, Steroids, NSAIDs, Immunosuppressant, Antimicrobials, Antiretroviral, Vasodilators, and Others), by Route of Administration (Topical, Parenteral, Oral, and Nasal), and by Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/nanoemulsion-market
The global nanoemulsion market is segmented on the basis of drug class, route of administration, and distribution channel. Based on drug class, the global nanoemulsion market includes anesthetics, steroids, NSAIDs, immunosuppressant, antimicrobials, antiretroviral, vasodilators, and others. NSAIDs are expected to register notable growth in the future, owing to the increasing NSAIDs usage for various applications, such as to reduce inflammation and pain. The immunosuppressant and antiretroviral drugs are expected to show high growth rates in the years ahead. By route of administration, the global nanoemulsion market includes topical, parenteral, oral, and nasal. The oral and topical routes of administration dominated the market in terms of revenue in 2018. By distribution channel, the global nanoemulsion market includes retail pharmacy, hospital pharmacy, and online pharmacy. Retail pharmacies are estimated to dominate the global nanoemulsion market over the estimated time period.
By region, North America is expected to dominate the global nanoemulsion market over the forecast time period. Well-established biotechnology and pharmaceutical and industries, rising number of research activities for new drug development, increasing prevalence of chronic disorders, growing technological advancements in drug delivery techniques across the region are expected to boost the North American nanoemulsion market in the years ahead. Asia Pacific nanoemulsion market is projected to grow at the highest rate during the projected time period, owing to the increasing income of people and altering regional demographics.
Some major players operating in the global nanoemulsion market are Mitsubishi Tanabe Pharma, AbbVie, Allergan, Fresenius Kabi, AstraZeneca, GlaxoSmithKline, Kaken Pharmaceutical, Sanofi, Novartis, and B. Braun Melsungen.
This report segments the global nanoemulsion market into:
Global Nanoemulsion Market: Drug Class Analysis
Global Nanoemulsion Market: Route of Administration Analysis
Global Nanoemulsion Market: Distribution Channel Analysis
Global Nanoemulsion Market: Regional Analysis
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651